Form 8-K - Current report:
SEC Accession No. 0001437749-20-008700
Filing Date
2020-04-28
Accepted
2020-04-28 16:27:28
Documents
3
Period of Report
2020-04-24
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20200428_8k.htm 8-K 29149
2 EXHIBIT 4.1 ex_183249.htm EX-4.1 81676
3 EXHIBIT 10.1 ex_183250.htm EX-10.1 72928
  Complete submission text file 0001437749-20-008700.txt   185054
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 20825451
SIC: 2834 Pharmaceutical Preparations